Aluminum

Subscribe to Selected New Research on Aluminum

1945 relevant articles (45 outcomes, 190 trials/studies) found for this Bio-Agent

Description: A metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98.

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Gibbs, Graham W: 3 articles (12/2007 - 10/2007)
2.	Sevigny, Maurice: 3 articles (12/2007 - 10/2007)
3.	Ghribi, Othman: 3 articles (07/2007 - 09/2006)
4.	Savory, John: 3 articles (07/2007 - 09/2006)
5.	Campbell, Arezoo: 3 articles (11/2006 - 04/2002)
6.	Walton, J R: 2 articles (09/2007 - 05/2006)
7.	Herman, Mary M: 2 articles (11/2006 - 09/2006)
8.	Rondeau, V: 2 articles (09/2006 - 07/2000)
9.	Commenges, D: 2 articles (09/2006 - 07/2000)
10.	Zatta, Paolo: 2 articles (09/2006 - 12/2003)

Related Diseases

1.	Poisoning 01/01/1997 - "The results provide evidence that Al-treated pups are capable of social learning (i.e., the performance of the avoidance response improved as a result that Al-treated learning); however, the response latency of the avoidance response was not different in these animals from those that were not exposed to such facilitation, suggesting that additional factors are involved in the effects of prenatal aluminum intoxication on cognitive processes." 03/01/1998 - "[Effect of aluminum poisoning and gamma-irradiation on the antioxidant system of the body and study of possibilities for correction]" 01/01/1985 - "The results from the present study demonstrate that the neuropathology, brain aluminum concentrations, and behavioral symptomatology produced by centrally administered Al can be replicated by administration of an adequate dose of peripherally administered Al. Furthermore, an advantage of peripheral Al administration over icv Al administration is that a longer period of time is seen between dosing and the full onset of the encephalopathy, providing more time to study the effects of Al intoxication." 04/01/2009 - "A case discussion of aluminum intoxication and review of the literature." 01/01/2008 - "Described later and initially associated with aluminum intoxication, these diseases are now seen primarily in older and/or diabetic patients, who in a uremic setting have relatively low levels of PTH to maintain normal bone turnover. " Order ALL the reference details at left...
2.	Bone Diseases (Bone Disease) 08/01/1990 - "[Experimental study of the mechanism of aluminum-induced bone disease]" 01/01/1988 - "The study outlines the metabolism of aluminum, the pathogenesis, prevalence, morbidity and mortality of aluminum-related bone disease, the histopathology of bone with aluminum accumulation, the recognized difficulties inherent in the diagnosis of aluminum-related bone disease, and the current understanding as relates to prevention and therapy." 01/01/1988 - "This editorial presents an overview of the most recent investigations of aluminum accumulation in humans, experimental animal models, and at the cellular level, presents the metabolic relationships known to exist as well as those strongly suggested in documented studies, and identifies those aspects of aluminum-related bone disease awaiting study in this increasingly important field of inquiry. " 12/01/1987 - "In the present study we attempted treatment of the aluminum-related bone disease with DFO, a potent chelating agent. " 02/01/1986 - "Experimental aluminum-induced bone disease: studies in vivo." Order ALL the reference details at left...
3.	Pain (Aches) 01/01/2003 - "[Joint and vertebral pain in workers of aluminum production]" 11/01/1989 - "With the exception of patients with bone pain, clinical signs and symptoms did not correlate with elevated serum aluminum. " 01/01/1986 - "Those seriously disabled with decreased mobility due to bone pain (7 of 13) had more bone aluminum than those patients with minimal or no disability (1.55 +/- 1.0 mm/mm2 vs. 0.11 +/- 0.18, respectively, p less than 0.01). " 04/01/1993 - "Walking by circular saws used to cut aluminum caused increasing pain at a previous laceration site. " 07/01/1985 - "The major symptoms of aluminum-related osteomalacia include skeletal pain, fractures, and vertebral collapse. " Order ALL the reference details at left...
4.	Osteomalacia 07/01/1991 - "The objectives for this study were to use this model to investigate the role of aluminum (Al) in both the induction and resolution of osteomalacia. " 01/01/1990 - "In the present study, PTH was continuously infused in rats with aluminum-induced osteomalacia to evaluate whether aluminum administration decreased mineralization without a concomitant decrease in osteoblasts. " 03/01/1988 - "Although aluminum exposure is associated with low-turnover osteomalacia, there are few studies of hepatotoxicity. " 11/01/1986 - "Because the concentration of aluminum used in this study is well within the range of serum aluminum levels seen in chronic dialysis patients, the direct effects of aluminum on osteoblast-mediated mineralization shown in the present study may underlie the development of so-called aluminum-induced "osteomalacia" in certain dialysis patients." 09/01/1986 - "In conclusion, these studies suggest that DFO and/or discontinuation of Al administration to rats with approximately 30% of renal function greatly improve aluminum-induced osteomalacia." Order ALL the reference details at left...
5.	Anemia 11/01/1985 - "It is clear, however, that aluminum in the dialysate can cause clinical problems including anemia, and that these problems can be substantially reduced if not eliminated by water treatment." 10/01/2004 - "These results suggest that erythrocyte aluminum accumulation could result in abnormal trace element homeostasis and increasing oxidative stress, which might be a mechanism of aluminum-induced anemia." 10/01/1994 - "Anemia affected the retention of Ga-67 more than the retention of aluminum; anemic rats retained more Ga-67 in their livers, spleens, kidneys, hearts, and muscles but less in their tibias than normal rats. " 09/01/1994 - "Investigation has proved that the exposure of rats to aluminum administered orally results in normocytic anemia." 01/01/1994 - "A possible factor in aluminum-associated anemia." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Deferoxamine (Desferal)
2.	Iron
3.	Calcium
4.	1-phenyl-3,3-dimethyltriazene (PDT)
5.	Zinc
6.	Sucralfate (Carafate)
7.	Calcium Carbonate (Limestone)
8.	Silicon
9.	Erythropoietin
10.	Magnesium

Related Therapies and Procedures

1.	Renal Dialysis (Hemodialysis)
2.	Aftercare (After-Treatment)
3.	Solid-State Lasers
4.	Injections
5.	Parathyroidectomy

Best Treatments:
Research Summary Report
on Poisoning

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 1076 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>